Navigation Links
Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
Date:9/17/2009

by co-principal investigator and project director for the partnership grant, Robert Linhardt, who is the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of Biocatalysis and Metabolic Engineering at Rensselaer. Linhardt, who was recently named one of the Scientific American 10, is among the world's foremost experts on heparin. His lab led the effort to find the contamination in 2008. And while Linhardt continues to develop more sophisticated detection systems to ensure a safer stream of drugs to the marketplace, he is also helping lead the race for a safer, man-made alternative to the traditional biologic heparin.

Linhardt helped discover the "recipe" for synthetic heparin three years ago with Jian Liu of the University of North Carolina. In August 2008, Linhardt announced that his team had constructed a milligram quantity of the purer, safer alternative creating the first fully synthetic heparin, and the largest amount ever created in the laboratory. Now he joins Dordick and fellow principal investigators Research Associate Professor of Chemical and Biological Engineering Fuming Zhang; Associate Professor Jian Liu from the University of North Carolina; and Professor Shaker Mousa from Albany College of Pharmacy, to scale up their capacity to manufacture the drug from a milligram to a kilogram a million-fold increase. A kilogram quantity of the drug would provide a strong foundation for the production of the millions of doses of the drug that would be required each year, according to the researchers.

"We believe a replacement for the currently available heparin is truly within our grasp," Linhardt said. "Some of the most important priorities of the research from here will be to create a simple and cost-effective process that can be easily replicated to produce a bioengineered, non-animal heparin at scales and cost sufficient to satisfy the therapeutic needs in the U.S."

The NIH grant totals nearly $4.7 million and will fund five
'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-276-6542
Rensselaer Polytechnic Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination
2. Trustee makes donation to start new solar energy research center at Rensselaer
3. Rensselaer receives more than $2 million from New York State to fund stem cell research
4. Meth exposure in young adults leads to long-term behavioral consequences
5. Seattle Childrens Hospital leads $23.7 million NIH grant to study gene repair
6. UD leads $5.3-million research project on rice epigenetics
7. UD leads $5.3-million research project on rice epigenetics
8. Nature leads the way for the next generation of paints, cosmetics and holograms
9. Massive microRNA scan uncovers leads to treating muscle degeneration
10. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
11. The construction of heart modelling leads path to new therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... ago, MIT professor John Essigmann and colleagues from the University ... They thought if they could induce the virus to mutate ... out a strategy that our immune system uses against ... which caused HIV to mutate at an enhanced rate, as ... in a small clinical trial reported in 2011. In a ...
(Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
(Date:7/28/2014)... MANHATTAN, Kansas He calls himself the bug hunter, ... that can only be found and identified with special ... at the Kansas State Veterinary Diagnostic Laboratory at Kansas ... his discoveries, porcine enterovirus G, which is an important ... a virus in cells, but didn,t know what it ...
Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3
... CORVALLIS, Ore. Researchers at Oregon State University ... the collapse of oyster seed production at a commercial ... to a level considered by the owners to be ... that elevated seawater carbon dioxide (CO2) levels, resulting in ...
... Mass. Copper the stuff of pennies and tea ... can turn carbon dioxide into hydrocarbon fuels with relatively little ... copper acts as a strong catalyst, setting off an electrochemical ... methane or methanol. Various researchers around the world have ...
... CO, USA -- April 10, 2012 -- HUNT Biosciences ... advance the clinical use of protein biomarkers, with an ... prediction of cardiovascular events such as strokes, heart attacks, ... samples and clinical data from HUNT Biosciences using SomaLogic,s ...
Cached Biology News:Ocean acidification linked to larval oyster failure 2Ocean acidification linked to larval oyster failure 3Hybrid copper-gold nanoparticles convert CO2 2Hybrid copper-gold nanoparticles convert CO2 3
(Date:7/28/2014)... 28, 2014 Research and Markets ... Biology Market 2014-2018" report to their offering. ... term synthetic biology covers the designing and engineering of ... as the redesigning of natural biological systems that provide ... a form of extreme genetic engineering because it not ...
(Date:7/28/2014)...   Propeller Health , the FDA-cleared digital health ... Brad Towle as Senior Vice President, Business ... the company,s sales growth, customer acquisition and program expansion. ... his past role in the development of accountable care ... pivotal time in the industry," said David Van ...
(Date:7/28/2014)... COLLEGE STATION, Texas , July 28, 2014   ... will be a 177-key, 4-star boutique hotel in the heart of ... , Texas.  Photo - http://photos.prnewswire.com/prnh/20140725/130455 ... first hotel within ATLAS , The ... of standard rooms and suites, a sleek restaurant and bar, a ...
(Date:7/25/2014)... 25, 2014 Amgen (NASDAQ: AMGN ... a $0.61 per share dividend for the third quarter ... 5, 2014, to all stockholders of record as of ... About Amgen Amgen is committed to unlocking ... illnesses by discovering, developing, manufacturing and delivering innovative human ...
Breaking Biology Technology:Global Synthetic Biology Market 2014-2018 2Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3
... LESS Instrumentation Is Selected for Industry Leader LESS Panel ... 29 Cambridge Endo, a pioneer in the rapidly ... or SPA) market, is pleased to announce that its ... leaders selected to be on a LESS panel at ...
... Laboratory InstrumentsMENLO PARK, Calif. and NORWOOD, Mass., Jan. ... today jointly announced that Advanced Instruments Inc. has ... The two companies further announced their intention ... generation of laboratory instruments for osmolality measurement, incorporating ...
... N.J., Jan. 29 Amicus Therapeutics (Nasdaq: ... 2008 financial results after the regular close of markets ... be followed by a live conference call and webcast ... investors may access the conference call at 5 p.m. ...
Cached Biology Technology:Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009 2Advanced Instruments Makes Strategic Investment in Cantimer, Inc. 2Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date 2
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
WNV Core Antibody...
... Rabbit polyclonal to FANCM ( Abpromise ... Antigen: Synthetic peptide derived from within ... FANCM. (Note: the amino acid sequence ... as ab27787 .) ...
Biology Products: